BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Denlinger CS, Sanft T, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Hudson M, Khakpour N, King A, Koura D, Lally RM, Langbaum TS, McDonough AL, Melisko M, Montoya JG, Mooney K, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Pirl W, Rodriguez MA, Ruddy KJ, Silverman P, Smith S, Syrjala KL, Tevaarwerk A, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA. Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2018;16:1216-47. [PMID: 30323092 DOI: 10.6004/jnccn.2018.0078] [Cited by in Crossref: 53] [Cited by in F6Publishing: 69] [Article Influence: 17.7] [Reference Citation Analysis]
Number Citing Articles
1 Martínez‐jaimez P, Fuster Linares P, Piller N, Masia J, Yamamoto T, López‐montoya L, Monforte‐royo C. Multidisciplinary preventive intervention for breast cancer‐related lymphedema: An international consensus. European J Cancer Care. [DOI: 10.1111/ecc.13704] [Reference Citation Analysis]
2 Misiąg W, Piszczyk A, Szymańska-chabowska A, Chabowski M. Physical Activity and Cancer Care—A Review. Cancers 2022;14:4154. [DOI: 10.3390/cancers14174154] [Reference Citation Analysis]
3 Cyr MP, Dostie R, Camden C, Dumoulin C, Bessette P, Pina A, Gotlieb WH, Lapointe-Milot K, Mayrand MH, Morin M. Acceptability of multimodal pelvic floor physical therapy to treat dyspareunia after gynecological malignancies: a qualitative study of women's views and experiences. Int Urogynecol J 2022. [PMID: 35947187 DOI: 10.1007/s00192-022-05304-4] [Reference Citation Analysis]
4 Benedict C, Fisher S, Kumar D, Pollom E, Schapira L, Kurian AW, Berek JS, Palesh O. Examining Associations Among Sexual Health, Unmet Care Needs, and Distress in Breast and Gynecologic Cancer Survivors. Semin Oncol Nurs 2022;:151316. [PMID: 35902337 DOI: 10.1016/j.soncn.2022.151316] [Reference Citation Analysis]
5 Muhandiramge J, Zalcberg JR, van Londen GJ, Warner ET, Carr PR, Haydon A, Orchard SG. Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology. Curr Oncol Rep 2022. [PMID: 35796941 DOI: 10.1007/s11912-022-01309-w] [Reference Citation Analysis]
6 Smith SR, Vargo M, Zucker DS, Shahpar S, Gerber LH, Henderson M, Jay G, Cheville AL. Responsiveness and interpretation of the PROMIS Cancer Function Brief 3D Profile. Cancer 2022. [PMID: 35788990 DOI: 10.1002/cncr.34376] [Reference Citation Analysis]
7 Starling CM, Greenberg D, Zhou E, Lewin D, Morrow AS, Lieberman D, Shaw C, Arem H. Testing delivery of components of cognitive behavioral therapy for insomnia to breast cancer survivors by smart speaker: a study protocol. BMC Med Inform Decis Mak 2022;22:163. [PMID: 35729605 DOI: 10.1186/s12911-022-01902-w] [Reference Citation Analysis]
8 Rushton M, Kappel C, Lima I, Tuna M, Pritchard K, Hawken S, Dent S. Cardiac Monitoring and Heart Failure in Advanced Breast Cancer Patients Treated With Trastuzumab in Ontario, Canada. Front Cardiovasc Med 2022;9:850674. [DOI: 10.3389/fcvm.2022.850674] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Torgbenu E, Luckett T, Buhagiar MA, Phillips JL. Guidelines Relevant to Diagnosis, Assessment, and Management of Lymphedema: A Systematic Review. Adv Wound Care (New Rochelle) 2022. [PMID: 35196892 DOI: 10.1089/wound.2021.0149] [Reference Citation Analysis]
10 Cuomo A, Mercurio V, Varricchi G, Galdiero MR, Rossi FW, Carannante A, Arpino G, Formisano L, Bianco R, Carlomagno C, De Angelis C, Giuliano M, Matano E, Picardi M, Salvatore D, De Vita F, Martinelli E, Della Corte CM, Morgillo F, Orditura M, Napolitano S, Troiani T, Tocchetti CG. Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients. ESC Heart Fail 2022. [PMID: 35362255 DOI: 10.1002/ehf2.13879] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Reese JB, El-jawahri A, Sorice K, Cruz C, Bober SL, Daly MB, Zimmaro LA, Beach MC, Wittenberg E, Wolff AC, Handorf E, Lepore SJ. Investigating the impact of the COVID-19 pandemic on breast cancer clinicians’ communication about sexual health. Support Care Cancer. [DOI: 10.1007/s00520-022-07003-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhao C, Grubbs A, Barber EL. Sleep and gynecological cancer outcomes: opportunities to improve quality of life and survival. Int J Gynecol Cancer 2022:ijgc-2022-003404. [PMID: 35331996 DOI: 10.1136/ijgc-2022-003404] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Abel MK, Morgan T, Othieno SA, Angeles A, Goldman M. Gynecological Management of the Breast Cancer Survivor. Best Practice & Research Clinical Obstetrics & Gynaecology 2022. [DOI: 10.1016/j.bpobgyn.2022.01.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhou Q, Doherty J, Akk A, Springer LE, Fan P, Spasojevic I, Halade GV, Yang H, Pham CTN, Wickline SA, Pan H. Safety Profile of Rapamycin Perfluorocarbon Nanoparticles for Preventing Cisplatin-Induced Kidney Injury. Nanomaterials (Basel) 2022;12:336. [PMID: 35159680 DOI: 10.3390/nano12030336] [Reference Citation Analysis]
15 Li X, Liang J, Qin A, Wang T, Liu S, Li W, Yuan C, Qu L, Zou W. Protective effect of Di'ao Xinxuekang capsule against doxorubicin-induced chronic cardiotoxicity. J Ethnopharmacol 2021;287:114943. [PMID: 34954266 DOI: 10.1016/j.jep.2021.114943] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Yang P, Zheng Y, Zhang L, Hou X. Incidence and characteristics of death from peptic ulcer among cancer patients in the United States. Sci Rep 2021;11:23579. [PMID: 34880278 DOI: 10.1038/s41598-021-00602-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Veeder JA, Hothem LN, Cipriani AE, Jensen BC, Rodgers JE. Chemotherapy-associated cardiomyopathy: Mechanisms of toxicity and cardioprotective strategies. Pharmacotherapy 2021;41:1066-80. [PMID: 34806206 DOI: 10.1002/phar.2638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Janssen SHM, van der Graaf WTA, van der Meer DJ, Manten-Horst E, Husson O. Adolescent and Young Adult (AYA) Cancer Survivorship Practices: An Overview. Cancers (Basel) 2021;13:4847. [PMID: 34638332 DOI: 10.3390/cancers13194847] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
19 Kobo O, Khattak S, Lopez-Mattei J, Van Spall HGC, Graham M, Cheng RK, Osman M, Sun L, Ullah W, Fischman DL, Roguin A, Mohamed MO, Mamas MA. Trends in cardiovascular mortality of cancer patients in the US over two decades 1999-2019. Int J Clin Pract 2021;75:e14841. [PMID: 34514707 DOI: 10.1111/ijcp.14841] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Figuracion KCF, Jung W, Martha SR. Ischemic Stroke Risk Among Adult Brain Tumor Survivors: Evidence to Guide Practice. J Neurosci Nurs 2021;53:202-7. [PMID: 34320512 DOI: 10.1097/JNN.0000000000000606] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Gilmore KR, Rodriguez MA. Identifying Optimal Program Models and Clinical Tools for Follow-Up Care. J Natl Cancer Inst Monogr 2021;2021:18-22. [PMID: 34478511 DOI: 10.1093/jncimonographs/lgab002] [Reference Citation Analysis]
22 Cuomo A, Paudice F, D'Angelo G, Perrotta G, Carannante A, Attanasio U, Iengo M, Fiore F, Tocchetti CG, Mercurio V, Pirozzi F. New-Onset Cancer in the HF Population: Epidemiology, Pathophysiology, and Clinical Management. Curr Heart Fail Rep 2021;18:191-9. [PMID: 34181210 DOI: 10.1007/s11897-021-00517-y] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
23 Yang K, Kim J, Chun M, Ahn MS, Chon E, Park J, Jung M. Factors to improve distress and fatigue in Cancer survivorship; further understanding through text analysis of interviews by machine learning. BMC Cancer 2021;21:741. [PMID: 34176470 DOI: 10.1186/s12885-021-08438-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Choi YJ, Park JH, Ko HH, Suh YJ. Surgical technique for lymphovenous bypass in patients with advanced lymphedema: Initial experience in a tertiary care center. Asian J Surg 2021;44:1110-1. [PMID: 34154939 DOI: 10.1016/j.asjsur.2021.05.031] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Nixon J, Chan R, McKinnell E, Ward E, Pinkham E, Wishart L, Miller E, Brown B. Rethinking the Meaning of "Wellness" for a Person with Cancer: A Qualitative Study to Explore What Elements Constitute "Wellness". Asia Pac J Oncol Nurs 2021;8:360-8. [PMID: 34159228 DOI: 10.4103/apjon.apjon-212] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Lee JE, Shin DW, Shin J, Cho IY, Lee J, Hwang J, Cho B, Song YM. A cross-sectional study of factors associated with influenza vaccination in Korean cancer survivors. Eur J Cancer Care (Engl) 2021;:e13443. [PMID: 33764597 DOI: 10.1111/ecc.13443] [Reference Citation Analysis]
27 Guha A, Dey AK, Al-Kindi S, Miller PE, Ghosh AK, Banerjee A, Lopez-Mattei J, Desai NR, Patel B, Oliveira GH, de Lima M, Fradley M, Addison D. Socio-Economic Burden of Myocardial Infarction Among Cancer Patients. Am J Cardiol 2021;141:16-22. [PMID: 33217349 DOI: 10.1016/j.amjcard.2020.11.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Scott LC, Yang Q, Dowling NF, Richardson LC. Predicted Heart Age Among Cancer Survivors - United States, 2013-2017. MMWR Morb Mortal Wkly Rep 2021;70:1-6. [PMID: 33411702 DOI: 10.15585/mmwr.mm7001a1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
29 Kozhukhov SM, Bazyka OY, Dovganych NV, Yarynkina OA, Tkhor NV. RADIOTHERAPY-ASSOCIATED CARDIOVASCULAR COMPLICATIONS IN CANCER (review). Probl Radiac Med Radiobiol 2020;25:56-74. [PMID: 33361829 DOI: 10.33145/2304-8336-2020-25-56-74] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Cuomo A, Pirozzi F, Attanasio U, Franco R, Elia F, De Rosa E, Russo M, Ghigo A, Ameri P, Tocchetti CG, Mercurio V. Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications. Curr Oncol Rep 2020;23:7. [PMID: 33263821 DOI: 10.1007/s11912-020-00990-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
31 Fujisawa D, Umemura S, Okizaki A, Satomi E, Yamaguchi T, Miyaji T, Mashiko T, Kobayashi N, Kinoshita H, Mori M, Morita T, Uchitomi Y, Goto K, Ohe Y, Matsumoto Y. Nurse-led, screening-triggered, early specialised palliative care intervention programme for patients with advanced lung cancer: study protocol for a multicentre randomised controlled trial. BMJ Open 2020;10:e037759. [PMID: 33243791 DOI: 10.1136/bmjopen-2020-037759] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 McMasters M, Blair BM, Lazarus HM, Alonso CD. Casting a wider protective net: Anti-infective vaccine strategies for patients with hematologic malignancy and blood and marrow transplantation. Blood Rev 2021;47:100779. [PMID: 33223246 DOI: 10.1016/j.blre.2020.100779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Peng JY, Pan FS, Wang W, Wang Z, Shan QY, Lin JH, Luo J, Zheng YL, Hu HT, Ruan SM, Liang JY, Xie XY, Lu MD. Malignancy risk stratification and FNA recommendations for thyroid nodules: A comparison of ACR TI-RADS, AACE/ACE/AME and ATA guidelines. Am J Otolaryngol 2020;41:102625. [PMID: 32668355 DOI: 10.1016/j.amjoto.2020.102625] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
34 Pang JH, Jones Z, Myers OB, Popek S. Long term sexual function following rectal cancer treatment. The American Journal of Surgery 2020;220:1258-63. [DOI: 10.1016/j.amjsurg.2020.06.064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Nassif TM, Brunelle CL, Gillespie TC, Bernstein MC, Bucci LK, Naoum GE, Taghian AG. Breast Cancer-Related Lymphedema: a Review of Risk Factors, Radiation Therapy Contribution, and Management Strategies. Curr Breast Cancer Rep 2020;12:305-16. [DOI: 10.1007/s12609-020-00387-8] [Reference Citation Analysis]
36 Maass SWMC, Boerman LM, Brandenbarg D, Verhaak PFM, Maduro JH, de Bock GH, Berendsen AJ. Symptoms in long-term breast cancer survivors: A cross-sectional study in primary care. Breast 2020;54:133-8. [PMID: 33035934 DOI: 10.1016/j.breast.2020.09.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
37 Xie F, You Y, Huang J, Guan C, Chen Z, Fang M, Yao F, Han J. Association between physical activity and digestive-system cancer: An updated systematic review and meta-analysis. J Sport Health Sci 2021;10:4-13. [PMID: 33010525 DOI: 10.1016/j.jshs.2020.09.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
38 Wen L, Wang S, Xu W, Xu X, Li M, Zhang Y, Du X, Liu S. Value of serum tumor markers for predicting EGFR mutations in non-small cell lung cancer patients. Ann Diagn Pathol 2020;49:151633. [PMID: 32977235 DOI: 10.1016/j.anndiagpath.2020.151633] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
39 Yin Q, Wang H, Cui H, Wang W, Yang G, Qie P, Xun X, Han S, Liu H. Meta-analysis of association between CT-based features and tumor spread through air spaces in lung adenocarcinoma. J Cardiothorac Surg 2020;15:243. [PMID: 32912289 DOI: 10.1186/s13019-020-01287-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
40 Brown JC, Ligibel JA. Putting Exercise Into Oncology Practice: State-of-the-Science, Innovation, and Future Directions. Cancer J 2019;25:316-9. [PMID: 31567458 DOI: 10.1097/PPO.0000000000000397] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
41 Battisti NML, Liposits G, De Glas NA, Gomes F, Baldini C, Mohile S. Systemic Therapy of Common Tumours in Older Patients: Challenges and Opportunities. A Young International Society of Geriatric Oncology Review Paper. Curr Oncol Rep 2020;22:98. [PMID: 32725503 DOI: 10.1007/s11912-020-00958-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
42 Bravo-jaimes K, Marcellon R, Varanitskaya L, Kim PY, Iliescu C, Gilchrist SC, Baldassarre LA, Manisty C, Ghosh AK, Guha A, Lopez-mattei JC. Opportunities for improved cardiovascular disease prevention in oncology patients. Current Opinion in Cardiology 2020;35:531-7. [DOI: 10.1097/hco.0000000000000767] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
43 Jiang L, Ping L, Yan H, Yang X, He Q, Xu Z, Luo P. Cardiovascular toxicity induced by anti-VEGF/VEGFR agents: a special focus on definitions, diagnoses, mechanisms and management. Expert Opin Drug Metab Toxicol 2020;16:823-35. [PMID: 32597258 DOI: 10.1080/17425255.2020.1787986] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Arem H, Scott R, Greenberg D, Kaltman R, Lieberman D, Lewin D. Assessing Breast Cancer Survivors' Perceptions of Using Voice-Activated Technology to Address Insomnia: Feasibility Study Featuring Focus Groups and In-Depth Interviews. JMIR Cancer 2020;6:e15859. [PMID: 32348274 DOI: 10.2196/15859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
45 Barac A, Isaacs C, M Shara N, Lynce F, Desale S, Haynes K, Potosky AL. Trends in the Use of Cardiac Imaging for Women with Newly Diagnosed Breast Cancer. J Cardiovasc Transl Res 2020;13:478-89. [PMID: 32458402 DOI: 10.1007/s12265-020-10023-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
46 Arem H, Mama SK, Duan X, Rowland JH, Bellizzi KM, Ehlers DK. Prevalence of Healthy Behaviors among Cancer Survivors in the United States: How Far Have We Come? Cancer Epidemiol Biomarkers Prev 2020;29:1179-87. [PMID: 32409489 DOI: 10.1158/1055-9965.EPI-19-1318] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
47 Gioffré S, Chiesa M, Cardinale DM, Ricci V, Vavassori C, Cipolla CM, Masson S, Sandri MT, Salvatici M, Ciceri F, Latini R, Staszewsky LI, Pompilio G, Colombo GI, D'Alessandra Y. Circulating MicroRNAs as Potential Predictors of Anthracycline-Induced Troponin Elevation in Breast Cancer Patients: Diverging Effects of Doxorubicin and Epirubicin. J Clin Med 2020;9:E1418. [PMID: 32403263 DOI: 10.3390/jcm9051418] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
48 Brunelle CL, Taghian AG. Lymphoedema screening: setting the standard. Br J Cancer 2020;123:1-2. [PMID: 32362657 DOI: 10.1038/s41416-020-0848-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
49 Schaverien MV, Baumann DP, Selber JC, Chang EI, Hanasono MM, Chu C, Hanson SE, Butler CE. Building a Multidisciplinary Comprehensive Academic Lymphedema Program. Plast Reconstr Surg Glob Open 2020;8:e2670. [PMID: 32537334 DOI: 10.1097/GOX.0000000000002670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
50 Cowgill JA, Francis SA, Sawyer DB. Anthracycline and Peripartum Cardiomyopathies. Circ Res 2019;124:1633-46. [PMID: 31120822 DOI: 10.1161/CIRCRESAHA.119.313577] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
51 Narayan V, Harrison M, Cheng H, Kenfield S, Aggarwal R, Kwon D, Mckay R, Hauger R, Hart N, Conzen S, Borno H, Jim H, Dicker A, Dorff T, Moslehi J, Mucci L, Parsons JK, Saad F, Soule H, Morgans A, Ryan CJ. Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group. Urologic Oncology: Seminars and Original Investigations 2020;38:83-93. [DOI: 10.1016/j.urolonc.2019.10.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
52 Ruddy KJ, Sangaralingham LR, Van Houten H, Nowsheen S, Sandhu N, Moslehi J, Neuman H, Jemal A, Haddad TC, Blaes AH, Villarraga HR, Thompson C, Shah ND, Herrmann J. Utilization of Cardiac Surveillance Tests in Survivors of Breast Cancer and Lymphoma After Anthracycline-Based Chemotherapy. Circ Cardiovasc Qual Outcomes 2020;13:e005984. [PMID: 32106704 DOI: 10.1161/CIRCOUTCOMES.119.005984] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
53 Park S, Sato Y, Takita Y, Tamura N, Ninomiya A, Kosugi T, Sado M, Nakagawa A, Takahashi M, Hayashida T, Fujisawa D. Mindfulness-Based Cognitive Therapy for Psychological Distress, Fear of Cancer Recurrence, Fatigue, Spiritual Well-Being, and Quality of Life in Patients With Breast Cancer-A Randomized Controlled Trial. J Pain Symptom Manage 2020;60:381-9. [PMID: 32105790 DOI: 10.1016/j.jpainsymman.2020.02.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
54 Ryan TD, Nagarajan R, Godown J. Cardiovascular Toxicities in Pediatric Cancer Survivors. Cardiol Clin. 2019;37:533-544. [PMID: 31587793 DOI: 10.1016/j.ccl.2019.07.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
55 Scott JM, Thomas SM, Peppercorn JM, Herndon JE 2nd, Douglas PS, Khouri MG, Dang CT, Yu AF, Catalina D, Ciolino C, Capaci C, Michalski MG, Eves ND, Jones LW. Effects of Exercise Therapy Dosing Schedule on Impaired Cardiorespiratory Fitness in Patients With Primary Breast Cancer: A Randomized Controlled Trial. Circulation. 2020;141:560-570. [PMID: 32065769 DOI: 10.1161/circulationaha.119.043483] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
56 Zhang W, Yi L, Shen J, Zhang H, Luo P, Zhang J. Comparison of the benefits of celecoxib combined with anticancer therapy in advanced non-small cell lung cancer: A meta-analysis. J Cancer 2020;11:1816-27. [PMID: 32194793 DOI: 10.7150/jca.35003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
57 He L, Qu H, Wu Q, Song Y. Lymphedema in survivors of breast cancer. Oncol Lett 2020;19:2085-96. [PMID: 32194706 DOI: 10.3892/ol.2020.11307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
58 Singh A, Decara JM. The Current and Future Role of Echocardiography for the Detection of Cardiotoxicity Related to Cancer Therapy. Curr Cardiovasc Imaging Rep 2020;13. [DOI: 10.1007/s12410-019-9523-3] [Reference Citation Analysis]
59 Sharma AV, Reddin G, Forrestal B, Barac A. Cardiovascular Disease Risk in Survivors of Breast Cancer. Curr Treat Options Cardiovasc Med 2019;21:79. [PMID: 31820123 DOI: 10.1007/s11936-019-0788-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
60 Galica J, Giroux J, Francis JA, Maheu C. Coping with fear of cancer recurrence among ovarian cancer survivors living in small urban and rural settings: A qualitative descriptive study. Eur J Oncol Nurs 2020;44:101705. [PMID: 32006720 DOI: 10.1016/j.ejon.2019.101705] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
61 Tucker K, Staley SA, Clark LH, Soper JT. Physical Activity: Impact on Survival in Gynecologic Cancer. Obstet Gynecol Surv 2019;74:679-92. [PMID: 31755545 DOI: 10.1097/OGX.0000000000000731] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
62 Mercurio V, Cuomo A, Della Pepa R, Ciervo D, Cella L, Pirozzi F, Parrella P, Campi G, Franco R, Varricchi G, Abete P, Marone G, Petretta M, Bonaduce D, Pacelli R, Picardi M, Tocchetti CG. What Is the Cardiac Impact of Chemotherapy and Subsequent Radiotherapy in Lymphoma Patients? Antioxidants & Redox Signaling 2019;31:1166-74. [DOI: 10.1089/ars.2019.7842] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
63 Zaorsky NG, Zhang Y, Tchelebi LT, Mackley HB, Chinchilli VM, Zacharia BE. Stroke among cancer patients. Nat Commun 2019;10:5172. [PMID: 31729378 DOI: 10.1038/s41467-019-13120-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 48] [Article Influence: 10.7] [Reference Citation Analysis]
64 Cho IY, Yoo JE, Ko H, Shin DW, Lee JW, Baek HJ, Chung N, Sung KW, Song Y. Influenza vaccination in caregivers of childhood cancer survivors. J Cancer Surviv 2019;13:993-1001. [DOI: 10.1007/s11764-019-00825-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
65 Goodlev ER, Discala S, Darnall BD, Hanson M, Petok A, Silverman M. Managing Cancer Pain, Monitoring for Cancer Recurrence, and Mitigating Risk of Opioid Use Disorders: A Team-Based, Interdisciplinary Approach to Cancer Survivorship. Journal of Palliative Medicine 2019;22:1308-17. [DOI: 10.1089/jpm.2019.0171] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
66 Seraphim A, Westwood M, Bhuva AN, Crake T, Moon JC, Menezes LJ, Lloyd G, Ghosh AK, Slater S, Oakervee H, Manisty CH. Advanced Imaging Modalities to Monitor for Cardiotoxicity. Curr Treat Options Oncol 2019;20:73. [PMID: 31396720 DOI: 10.1007/s11864-019-0672-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
67 Sun V, Bakitas M. Palliative and Supportive Care: …End of the Beginning. West J Nurs Res 2019;41:1343-6. [DOI: 10.1177/0193945919861017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
68 Lee Chuy K, Nahhas O, Dominic P, Lopez C, Tonorezos E, Sidlow R, Straus D, Gupta D. Cardiovascular Complications Associated with Mediastinal Radiation. Curr Treat Options Cardio Med 2019;21. [DOI: 10.1007/s11936-019-0737-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
69 Hardaway BW. Adriamycin-associated cardiomyopathy: where are we now? updates in pathophysiology, dose recommendations, prognosis, and outcomes. Current Opinion in Cardiology 2019;34:289-95. [DOI: 10.1097/hco.0000000000000617] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]